VIC Technology Venture Development primarily is focused on building companies around high-impact life science technologies, including medical devices, therapeutics, diagnostics, and advanced instrumentation. More than...
This month, CardioWise filed a 510(k) Application for its machine learning-based heart health analysis software known as SQuEEZTM. The software, combined with cardiac computerized tomography (CT) imaging, has the...
Startups are known to be roller coaster rides, but what do you get when you launch an automotive industry startup? A really wild ride! The past year or so has indeed been a wild ride since I took over as CEO of...
With workers, communities and corporations around the globe joining the battle against COVID-19, one company is attacking the virus from an unexpected angle: water.
Our current daily activities bear little resemblance to the routines as of as recently as a month ago. COVID-19 has had an obvious and significant impact on the American people. For those suffering from chronic...
“Did you eat too much candy as a child?” “You don’t look diabetic…you are not at all overweight.” “You just have to watch your sugar intake, right?” These are typical, insensitive comments that people with diabetes...
Neurexis Therapeutics, Inc. to develop a new medication for the prevention of brain damage following ischemic events such as stroke
The VIC Fellows Program was created as a mechanism through which individuals with specific expertise can learn about and be involved in the process of identifying and evaluating promising life science innovation from...
Company co-founded with Reza Foudazi, PhD, developer of a platform membrane technology with broad applications in bioprocessing and industrial filtration.
Startups are pulling outsized financing rounds and debt acquisitions at an unprecedented rate despite the high 80 percent failure rate of startups overall. Among the three primary reasons why startups tend to fail,...
FEATURED RESOURCES
